secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coya Therapeutics, Inc. (COYA)
CIK:        0001835022
Form:       8-K
Filed at:   2024-05-08T23:59:59+00:00
Accession:  0001193125-24-134376
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Coya Therapeutics stockholders approve 750,000 share increase to equity incentive plan
--------------------------------------------------------------------------------

- Amendment to 2021 Equity Incentive Plan adds 750,000 shares, raising total authorized to 2,571,070.
- Class II directors elected: Anabella Villalobos, Ph.D. and Dov Goldstein, M.D., M.B.A.
- Shareholders ratified Weaver and Tidwell, L.L.P. as independent auditor for FY2024.
- All three proposals passed with required votes, including broker non-votes on director and plan items.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835022/000119312524134376/0001193125-24-134376-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835022/000119312524134376/d837317d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-134376

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer